查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594515

食用動物非治療性抗生素市場：依抗生素類別、給藥途徑、目標動物和抗生素活性成分分類－2025-2030年全球預測

Non-Therapeutic Antibiotics for Food Animals Market by Antibiotic Class, Route of Administration, Target Animal, Antibiotic Active Ingredient - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年食用動物非治療性抗生素市值為47.9億美元，預計2024年將達51.3億美元，複合年成長率為7.18%，到2030年將達到77.9億美元，預計將達到90美元百萬。

食用動物非治療性抗生素市場的範圍和定義是出於治療疾病以外的原因而使用抗生素，主要是為了促進家禽、牛、豬等牲畜的生長，並以提高飼料效率為目的。對此類抗生素的需求源於對高品質肉類、雞蛋和酪農，而這需要高效的生產系統。這些抗生素用於預防性施用，以維持疾病傳播風險增加的集中農業作業中的動物健康和生產力。然而，監管壓力和消費者意識正在改變最終用途的範圍，減少抗生素的使用並青睞益生菌和有機農業等替代品。

主要市場統計
基準年[2023] 47.9億美元
預測年份 [2024] 51.3億美元
預測年份 [2030] 77.9億美元
複合年成長率（%） 7.18%

該市場的關鍵成長要素包括全球肉品消費量的增加、畜牧業的進步以及獸醫健康的持續研究。新的商機在於開發益生元和植物源等抗生素替代品，以及加強農場的生物安全措施。然而，市場面臨重大挑戰，包括限制抗生素使用的嚴格法規、消費者對不含抗生素產品的偏好增加以及始終存在的抗菌素抗藥性 (AMR) 威脅。這些因素需要採取平衡的方法，利用創新研究來提高效率，同時又不損害公共衛生或動物福利。

創新極為重要，例如基於奈米技術的藥物輸送系統、精準營養以及牲畜天然抵抗疾病的基因進步。這些行業預計不僅能夠滿足更嚴格的法規，而且在品質和永續性方面具有優勢。公司應該投資於研發夥伴關係以及與學術機構的合作來開拓這些解決方案。因此，市場正在朝著永續成長的方向發展，需要依靠道德生產、高效和可追溯的供應鏈來有效滿足消費者的期望和監管要求。對於希望在這個充滿活力的市場環境中生存並蓬勃發展的企業來說，解決這些因素至關重要。

市場動態：快速發展的食用動物非治療性抗生素市場的關鍵市場洞察

供需的動態交互作用正在改變食用動物的非治療性抗生素市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球對動物性蛋白質的需求不斷增加
    • 增加使用以提高產量和預防疾病
  • 市場限制因素
    • 關於非治療性抗生素使用的嚴格政府法規
  • 市場機會
    • 政府措施
  • 市場挑戰
    • 對植物來源肉類的需求不斷增加

波特五力：開拓食用動物非治療性抗生素市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對食用動物非治療性抗生素市場的外部影響

外部宏觀環境因素在影響食用動物非治療性抗生素市場表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解食用動物非治療性抗生素市場的競爭格局

對食用動物市場非治療性抗生素的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

食品動物非治療性抗生素市場供應商的 FPNV 定位矩陣績效評估

FPNV定位矩陣是評估食用動物非治療性抗生素市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為食用動物非治療性抗生素市場的成功指明道路

對於旨在加強其在全球市場的影響力的公司來說，對食用動物非治療性抗生素市場進行策略性分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球對動物性蛋白質的需求增加
      • 增加使用以提高生產力和預防疾病
    • 抑制因素
      • 關於非治療性抗生素使用的嚴格政府法規
    • 機會
      • 加強政府努力發展水產養殖業
    • 任務
      • 對植物來源肉品的需求增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 依抗生素類型分類的食用動物非治療性抗生素市場

  • 醫學上重要的
    • Aminoglycosides
    • 頭孢菌素
    • 蘭考醯胺
    • 大環內酯
    • 青黴素
    • 磺胺類藥物
    • 四環黴素
  • 在醫學上不重要
    • 離子載體

第7章食用動物用非治療性抗生素市場：依給藥途徑

  • 配合飼料
  • 飼料混合物
  • 飼料預混合料
  • 水

第8章 食用動物非治療性抗生素市場 目標動物

  • 水產飼料
  • 牛飼料
  • 家禽飼料
  • 豬飼料

第9章 食用動物非治療性抗生素市場 抗生素有效成分

  • Ampicillin和阿莫西林
  • 桿菌胜肽
  • 慶大霉素
  • 四環黴素
  • 沙利黴素
  • 磺胺喹喔啉
  • 泰樂菌素

第10章：美洲食用動物非治療性抗生素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太食用動物非治療性抗生素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲食用動物非治療性抗生素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alfasan Group of Companies
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Engormix
  • F. Hoffmann-La Roche Ltd.
  • Huvepharma
  • Kremoint Pharma Pvt. Ltd.
  • Lupin Limited
  • Merck KGaA
  • Novartis AG
  • Sanofi SA
  • Vega Group company limited
  • Vetoquinol SA
  • Virbac
Product Code: MRR-036C5CF3B529

The Non-Therapeutic Antibiotics for Food Animals Market was valued at USD 4.79 billion in 2023, expected to reach USD 5.13 billion in 2024, and is projected to grow at a CAGR of 7.18%, to USD 7.79 billion by 2030.

The scope and definition of the non-therapeutic antibiotics market for food animals encompass the use of antibiotics for reasons beyond treating diseases, primarily to promote growth and improve feed efficiency in livestock such as poultry, cattle, and swine. The necessity of such antibiotics arises from the increasing demand for high-quality meat, eggs, and dairy, which requires efficient production systems. These antibiotics are applied prophylactically to maintain animal health and productivity in intensive farming operations where disease transmission risk is heightened. However, the end-use scope is witnessing a shift due to regulatory pressures and consumer awareness, pushing for reduced antibiotic use and favoring alternatives like probiotics and organic farming practices.

KEY MARKET STATISTICS
Base Year [2023] USD 4.79 billion
Estimated Year [2024] USD 5.13 billion
Forecast Year [2030] USD 7.79 billion
CAGR (%) 7.18%

Key growth influencers in this market include the rising global meat consumption, advancements in animal husbandry practices, and ongoing research in veterinary health. Emerging opportunities lie in developing antibiotic alternatives, such as prebiotics and phytogenics, and enhancing biosecurity measures in farms. However, the market faces significant challenges, such as stringent regulations limiting antibiotic use, increasing consumer preference for antibiotic-free products, and the ever-present threat of antimicrobial resistance (AMR). These factors necessitate a balanced approach, leveraging innovative research to enhance efficiencies without compromising public health or animal welfare.

Innovation is critical, with prospects in nanotechnology-based drug delivery systems, precision nutrition, and genetic advancements in livestock to naturally resist diseases. These areas promise not only to align with stricter regulations but also provide an edge in quality and sustainability. Companies should invest in R&D partnerships and collaborations with academic institutions to pioneer these solutions. Consequently, the market is evolving towards sustainable growth, demanding a strategic focus on ethically produced, efficient, and traceable supply chains to meet consumer expectations and regulatory demands effectively. Addressing these factors is vital for businesses aiming to not only survive but also thrive in this dynamic market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-Therapeutic Antibiotics for Food Animals Market

The Non-Therapeutic Antibiotics for Food Animals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for animal protein globally
    • Rising use for increasing production and prevention from diseases
  • Market Restraints
    • Stringent government regulations on use of non-therapeutic antibiotics
  • Market Opportunities
    • Increasing government initiatives for development of aquaculture
  • Market Challenges
    • Increasing demand for plant-based meat products

Porter's Five Forces: A Strategic Tool for Navigating the Non-Therapeutic Antibiotics for Food Animals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-Therapeutic Antibiotics for Food Animals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-Therapeutic Antibiotics for Food Animals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-Therapeutic Antibiotics for Food Animals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-Therapeutic Antibiotics for Food Animals Market

A detailed market share analysis in the Non-Therapeutic Antibiotics for Food Animals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-Therapeutic Antibiotics for Food Animals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-Therapeutic Antibiotics for Food Animals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-Therapeutic Antibiotics for Food Animals Market

A strategic analysis of the Non-Therapeutic Antibiotics for Food Animals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-Therapeutic Antibiotics for Food Animals Market, highlighting leading vendors and their innovative profiles. These include Alfasan Group of Companies, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Engormix, F. Hoffmann-La Roche Ltd., Huvepharma, Kremoint Pharma Pvt. Ltd., Lupin Limited, Merck KGaA, Novartis AG, Sanofi S.A., Vega Group company limited, Vetoquinol SA, and Virbac.

Market Segmentation & Coverage

This research report categorizes the Non-Therapeutic Antibiotics for Food Animals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Antibiotic Class, market is studied across Medically Important and Non-Medically Important. The Medically Important is further studied across Aminoglycosides, Cephalosporin, Lancosamides, Macrolide, Penicillin, Sulfas, and Tetracyclines. The Non-Medically Important is further studied across Ionophores.
  • Based on Route of Administration, market is studied across Compound Feed, Feed Mixtures, Feed Premix, and Water.
  • Based on Target Animal, market is studied across Aqua Feed, Cattle Feed, Poultry Feed, and Swine Feed.
  • Based on Antibiotic Active Ingredient, market is studied across Ampicillin & Amoxycillin, Bacitracin, Gentamicin, Oxytetracyclines, Salinomycin, Sulfaquinoxaline, and Tylosin.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for animal protein globally
      • 5.1.1.2. Rising use for increasing production and prevention from diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent government regulations on use of non-therapeutic antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing government initiatives for development of aquaculture
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing demand for plant-based meat products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Non-Therapeutic Antibiotics for Food Animals Market, by Antibiotic Class

  • 6.1. Introduction
  • 6.2. Medically Important
    • 6.2.1. Aminoglycosides
    • 6.2.2. Cephalosporin
    • 6.2.3. Lancosamides
    • 6.2.4. Macrolide
    • 6.2.5. Penicillin
    • 6.2.6. Sulfas
    • 6.2.7. Tetracyclines
  • 6.3. Non-Medically Important
    • 6.3.1. Ionophores

7. Non-Therapeutic Antibiotics for Food Animals Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Compound Feed
  • 7.3. Feed Mixtures
  • 7.4. Feed Premix
  • 7.5. Water

8. Non-Therapeutic Antibiotics for Food Animals Market, by Target Animal

  • 8.1. Introduction
  • 8.2. Aqua Feed
  • 8.3. Cattle Feed
  • 8.4. Poultry Feed
  • 8.5. Swine Feed

9. Non-Therapeutic Antibiotics for Food Animals Market, by Antibiotic Active Ingredient

  • 9.1. Introduction
  • 9.2. Ampicillin & Amoxycillin
  • 9.3. Bacitracin
  • 9.4. Gentamicin
  • 9.5. Oxytetracyclines
  • 9.6. Salinomycin
  • 9.7. Sulfaquinoxaline
  • 9.8. Tylosin

10. Americas Non-Therapeutic Antibiotics for Food Animals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Non-Therapeutic Antibiotics for Food Animals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alfasan Group of Companies
  • 2. Boehringer Ingelheim GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Engormix
  • 6. F. Hoffmann-La Roche Ltd.
  • 7. Huvepharma
  • 8. Kremoint Pharma Pvt. Ltd.
  • 9. Lupin Limited
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. Sanofi S.A.
  • 13. Vega Group company limited
  • 14. Vetoquinol SA
  • 15. Virbac

LIST OF FIGURES

  • FIGURE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET RESEARCH PROCESS
  • FIGURE 2. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET DYNAMICS
  • TABLE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY LANCOSAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COMPOUND FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MIXTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED PREMIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUA FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN & AMOXYCILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY BACITRACIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAQUINOXALINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 20